1196-07-2

Usage

Uses

Used in Organic Chemistry:
Methyl 5-bromo-1-methyl-1H-pyrrole-2-carboxylate is used as a building block for the synthesis of various biologically active molecules, contributing to the development of complex organic compounds.
Used in Medicinal Chemistry:
In the field of medicinal chemistry, Methyl 5-bromo-1-methyl-1H-pyrrole-2-carboxylate is utilized as an intermediate in the production of pharmaceuticals, playing a crucial role in the synthesis of drugs with potential therapeutic applications.
Used in Agrochemicals Production:
Methyl 5-bromo-1-methyl-1H-pyrrole-2-carboxylate is also employed as an intermediate in the production of agrochemicals, aiding in the development of compounds with applications in agriculture for pest control and crop protection.

Upstream product

• 128-08-5 N-Bromosuccinimide 
• 37619-24-2 methyl N-methylpyrrole-2-carboxylate 

Downstream Products

• 1413064-18-2 5-[2-acetoxymethyl-3-(6-tert-butyl-1-oxo-1H-phthalazin-2-yl)-phenyl]-1-methyl-1H-pyrrole-2-carboxylic acid methyl ester 

Relevant academic research and scientific papers

COMPOUND ACTING AS ANTIBIOTICS

The present invention provides a novel antibiotic compound represented by the following formula (I), a pharmaceutically acceptable salt thereof, an ester thereof, a prodrug thereof, a solvate thereof, or a deuterated analog thereof, or a stereoisomer thereof. The compound of the present invention exhibits excellent antibacterial activity, especially against Gram bacteria. wherein each group is defined as in the description.

CYCLIC AMINE SUBSTITUTED OXAZOLIDINONE CETP INHIBITOR

CCompounds having the structure of Formula I, including pharmaceutically acceptable salts of the compounds, are CETP inhibitors and are useful for raising HDL-cholesterol, reducing LDL-cholesterol, and for treating or preventing atherosclerosis. In the compound of Formula I, A3 is a substitiuted phenyl group or indanyl group.Formula (I)

2-AMINOQUINAZOLINE DERIVATIVE

The present invention provides a compound represented by Formula (I) (wherein R 1 and R 2 are the same or different, and each represents a hydrogen atom, substituted or unsubstituted lower alkyl and the like, R 3 represents substituted or unsubstituted aryl, a substituted or unsubstituted aromatic heterocyclic group and the like, R 4 and R 5 are the same or different, and each represents a hydrogen atom, halogen, substituted or unsubstituted lower alkyl, substituted or unsubstituted aryl and the like, proviso that they are not simultaneously hydrogen atoms, and R 6 represents hydroxy or substituted or unsubstituted lower alkoxy), or a pharmaceutically acceptable salt thereof and the like.

Azabicyclic-substituted-heteroaryl compounds for the treatment of disease

The invention provides compounds of Formula I: Azabicyclo-N(R1)—C(═X)—W??Formula I These compounds may be in the form of pharmaceutical salts or compositions, racemic mixtures, or pure enantiomers thereof. The compounds of Formula I are useful